Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

News

Sygnature is proud of its many achievements, research collaborations and awards and delighted to publish these achievements wherever possible. Below you can read and hear about exciting new developments within the organization.

Filter by:

News

Our new Chairman: Dr Charles Woler

READ ARTICLE

News

Sygnature strengthens with MedChemica software solution

READ ARTICLE

News

Expansions, transactions and all action: Our 2021 recap!

READ ARTICLE

News

New CFO Jordison steps up

READ ARTICLE

News

Sygnature collaborates with Japanese bio-venture company Epigeneron

READ ARTICLE

Drug Discovery News

Five Arrows invests in Sygnature Discovery

READ ARTICLE

Drug Discovery News

Sygnature Discovery expands into early CMC development

READ ARTICLE

News

Sygnature gains ISO:27001 certification for information security

READ ARTICLE

News

Sygnature appoints Dr David Lustig to spearhead US expansion

READ ARTICLE

Drug Discovery News

Sygnature Discovery expands US presence with Bay Area office

READ ARTICLE

News

Freak chemistry accident turns Sygnature’s Senior VP – Alliance Management into legendary werewolf

READ ARTICLE

DMPK in vivo pharmacology News

Three of UK’s top drug discovery CROs join forces under the name Sygnature Discovery

READ ARTICLE
MORE...